Association of Serum Bilirubin Levels with Macro- and Microvascular Complications in Chinese People with Type 2 Diabetes Mellitus: New Insight on Gender Differences

Background Previous studies suggested protective effects of bilirubin against cardiovascular disease, with a possible gender difference. However, the relationship between serum total bilirubin (TBIL) with diabetic macro- and microvascular complications remains unknown. We aimed to examine the association of macro- and microvascular complications with serum TBIL levels. Methods Serum TBIL was measured in 648 patients with T2DM. Demographic and clinical data were obtained from the inpatient medical record system. Serum TBIL was measured with an automatic biochemistry analyzer according to routine protocols. Parameters of vascular complications, including ankle-brachial index, carotid intima-media thickness, estimated glomerular filtration rate and the urinary albumin to creatinine ratio, were measured and calculated. The association between TBIL and diabetic macro- and microvascular complications was analyzed. Results In multivariable logistic regression, after adjustment for age, sex, body mass index and diabetic duration, higher serum TBIL levels were significantly associated with decreased odds of microalbuminuria (OR = 0.31, [95% CI] 0.16–0.61, P = 0.003) and chronic kidney disease (OR = 0.19, [95% CI] 0.09–0.41, P < 0.001). These associations were only found in male but not in female patients. However, no significant relationship was found between TBIL and peripheral arterial disease or carotid hypertrophy. Conclusion Our findings suggest that physiological higher TBIL level might be a protective factor for diabetic microvascular complications.

[1]  Qinhui Liu,et al.  Immune responses in diabetic nephropathy: Pathogenic mechanisms and therapeutic target , 2022, Frontiers in Immunology.

[2]  Bo Peng,et al.  Lifestyle and chronic kidney disease: A machine learning modeling study , 2022, Frontiers in Nutrition.

[3]  R. Takayanagi,et al.  Association of serum total bilirubin levels with progressive renal decline and end-stage kidney disease: 10-year observational cohort study in Japanese patients with diabetes , 2022, PloS one.

[4]  George J. Dugbartey,et al.  Activation of renal CSE/H2S pathway by alpha-lipoic acid protects against histological and functional changes in the diabetic kidney. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[5]  Zhangsuo Liu,et al.  Mechanistic Pathogenesis of Endothelial Dysfunction in Diabetic Nephropathy and Retinopathy , 2022, Frontiers in Endocrinology.

[6]  J. Björkegren,et al.  Atherosclerosis: Recent developments , 2022, Cell.

[7]  H. Bao,et al.  Association of Plasma Bilirubin Levels With Peripheral Arterial Disease in Chinese Hypertensive Patients: New Insight on Sex Differences , 2022, Frontiers in Physiology.

[8]  P. Reddy,et al.  Oxidative stress in the pathophysiology of type 2 diabetes and related complications: Current therapeutics strategies and future perspectives. , 2022, Free radical biology & medicine.

[9]  Zhengming Chen,et al.  Menopausal status, age at natural menopause and risk of diabetes in China: a 10-year prospective study of 300,000 women , 2022, Nutrition & Metabolism.

[10]  Xiaomei Dong,et al.  Dose-Response Association Between Bilirubin and Cardiovascular Disease: A Systematic Review and Meta-analysis , 2022, Angiology.

[11]  Jinbao Liu,et al.  Bilirubin ameliorates murine atherosclerosis through inhibiting cholesterol synthesis and reshaping the immune system , 2022, Journal of translational medicine.

[12]  V. Novack,et al.  The Association of Alanine Aminotransferase Levels With Myocardial Perfusion Imaging and Cardiovascular Morbidity , 2022, Journal of cardiovascular pharmacology and therapeutics.

[13]  J. Olefsky,et al.  Inflammation in obesity, diabetes, and related disorders. , 2022, Immunity.

[14]  Zane C. Giffen,et al.  Serum bilirubin as a predictor of graft outcomes after renal transplant. , 2022, American journal of clinical and experimental urology.

[15]  T. Yasu Comprehensive cardiac rehabilitation program for peripheral arterial diseases. , 2021, Journal of cardiology.

[16]  A. El-Kadi,et al.  Sex differences in eicosanoid formation and metabolism: A possible mediator of sex discrepancies in cardiovascular diseases. , 2021, Pharmacology & therapeutics.

[17]  M. Bechara,et al.  Metabolic syndrome and cardiovascular diseases: Going beyond traditional risk factors , 2021, Diabetes/metabolism research and reviews.

[18]  W. Rathmann,et al.  Incidence Rates and Predictors of Microvascular and Macrovascular Complications in Patients with Type 2 Diabetes: Results from the Longitudinal Global DISCOVER Study. , 2021, American heart journal.

[19]  J. Xia,et al.  Serum Bilirubin Levels and Extent of Symptomatic Intracranial Atherosclerotic Stenosis in Acute Ischemic Stroke: A Cross-Sectional Study , 2021, Frontiers in Neurology.

[20]  Huafang Li,et al.  Sex differences between serum total bilirubin levels and cognition in patients with schizophrenia , 2021, BMC Psychiatry.

[21]  Y. Jeong,et al.  The Anti-Inflammatory Role of Bilirubin on “Two-Hit” Sepsis Animal Model , 2020, International journal of molecular sciences.

[22]  Hongyu Wang,et al.  The Relationship Between Serum Bilirubin Levels and Peripheral Arterial Disease and Gender Difference in Patients With Hypertension: BEST Study , 2020, Angiology.

[23]  J. Shaw,et al.  Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. , 2019, Diabetes research and clinical practice.

[24]  P. Zhong,et al.  Total bilirubin is negatively related to diabetes mellitus in Chinese elderly: a community study. , 2019, Annals of translational medicine.

[25]  Ximin Fan,et al.  Association between macro- and microvascular damage and the triglyceride glucose index in community-dwelling elderly individuals: the Northern Shanghai Study , 2019, Cardiovascular diabetology.

[26]  Miao Liu,et al.  The U-Shaped Association between Bilirubin and Diabetic Retinopathy Risk: A Five-Year Cohort Based on 5323 Male Diabetic Patients , 2018, Journal of diabetes research.

[27]  Jian Wang,et al.  Inverse Relationship Between Serum Bilirubin Levels and Diabetic Foot in Chinese Patients with Type 2 Diabetes Mellitus , 2017, Medical science monitor : international medical journal of experimental and clinical research.

[28]  Christine Maric-Bilkan Sex differences in micro- and macro-vascular complications of diabetes mellitus. , 2017, Clinical science.

[29]  Miao Liu,et al.  Elevated serum total bilirubin levels are negatively associated with major diabetic complications among Chinese senile diabetic patients. , 2017, Journal of diabetes and its complications.

[30]  M. Mahfouz,et al.  Effect of resveratrol and rosuvastatin on experimental diabetic nephropathy in rats. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[31]  K. Kohara,et al.  Association between Serum Bilirubin and Estimated Glomerular Filtration Rate among Diabetic Patients , 2015, International scholarly research notices.

[32]  P. Smits,et al.  The Bilirubin-Increasing Drug Atazanavir Improves Endothelial Function in Patients With Type 2 Diabetes Mellitus , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[33]  R. Takayanagi,et al.  Bilirubin and biliverdin protect rodents against diabetic nephropathy by downregulating NAD(P)H oxidase. , 2010, Kidney international.

[34]  S. Ito,et al.  Clinical Practice Guidebook for Diagnosis and Treatment of Chronic Kidney Disease , 2009 .

[35]  N. Nakamura,et al.  Relationship between serum bilirubin and albuminuria in patients with type 2 diabetes. , 2008, Kidney international.

[36]  Solomon H. Snyder,et al.  Biliverdin reductase: A major physiologic cytoprotectant , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[37]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.